UK markets close in 5 hours 42 minutes

Akari Therapeutics, Plc (AKTX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.52000.0000 (0.00%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-9,890
-17,748
-17,424
-17,082
Depreciation & amortisation
3.61
4
4.126
8.907
Stock-based compensation
1,055
735
314.65
325.523
Change in working capital
2,757
822
-1,984
-55.629
Other working capital
-17,455
-21,504
-18,847
-16,950
Other non-cash items
-
-
-
900
Net cash provided by operating activities
-17,455
-21,504
-18,847
-16,950
Cash flows from financing activities
Common stock issued
16,329
25,194
14,293
25,046
Net cash used provided by (used for) financing activities
16,424
25,288
14,293
25,074
Net change in cash
-970.489
3,889
-4,695
8,324
Cash at beginning of period
8,151
9,361
14,056
5,732
Cash at end of period
7,121
13,250
9,361
14,056
Free cash flow
Operating cash flow
-17,455
-21,504
-18,847
-16,950
Free cash flow
-17,455
-21,504
-18,847
-16,950